From ethical questions for neurologists and clinical research to an omicron-focused vaccine, each week we highlight five things to know in life sciences. … READ MORE >
vaccine
5 things to know in life sciences: Week of September 6
From vaccine mandate updates to “variant hunters,” each week we highlight five things you need to know in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of June 14
From tools to support decentralized clinical trials to new efforts to reduce systemic racism in medical research, each week we highlight five things you need to know about in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of March 22
This week we highlight AstraZeneca-Oxford COVID-19 vaccine challenges, FDA trends, drug-pricing reform hearings and more. … READ MORE >
CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements
Local facilities face logistical hurdles in maintaining the ultra-low storage temps needed for COVID-19 vaccines. This graphic shows how the vaccines from Pfizer, Moderna and Johnson & Johnson compare in terms of their storage requirements. … READ MORE >
5 things to know in life sciences: Week of Feb. 1
This week, we look at mRNA drug manufacturing capacity, gene therapy investments, news of a new FDA role dedicated to medical device cybersecurity, and more. … READ MORE >
5 things to know in life sciences: Week of Jan. 18
This week, we look at new officials in the government’s COVID-19 response effort, how changes in technology and bioethics are driving clinical trial diversity, and how robotics continues to change surgery and medical device manufacturing. … READ MORE >
5 things to know this week in life sciences: Week of Jan. 4
In this week’s industry roundup, we look at recent drug price increases, the ongoing battle over 340B program discounts, key catalysts in Q1 for middle market biotech companies, and more. … READ MORE >
5 things to know this week in life sciences: Week of Dec. 21
With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated. But this is also a good time to reflect on the decades of work that laid the groundwork for this lightning fast vaccine development effort. … READ MORE >
CHART OF THE DAY: Vaccine doses for the global population
With the U.S. Food and Drug Administration set to review Pfizer and BioNTech’s COVID-19 vaccine this week for emergency use authorization and Moderna’s vaccine next week, we have passed the “if” phase of questions around a COVID-19 vaccine and are now in the midst of determining the “when and how” of vaccine distribution. … READ MORE >